9 CFR Subject Group
Antibody Products
August 7, 2025
§
113.450
General requirements for antibody products
§
113.451
Tetanus Antitoxin
§
113.452
Erysipelothrix Rhusiopathiae Antibody
§
113.453
§ 113.453 [Reserved]
§
113.454
Clostridium Perfringens Type C Antitoxin
§
113.455
Clostridium Perfringens Type D Antitoxin
§
113.456-113.498
§§ 113.456-113.498 [Reserved]
§
113.499
Products for treatment of failure of passive transfer